Pnc Financial Services Group, Inc. Rapt Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 78 shares of RAPT stock, worth $88. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78
Previous 78
-0.0%
Holding current value
$88
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
103Shares Held
49.4MCall Options Held
26.7KPut Options Held
2.4K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$25.5 Million7.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$3.6 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$3.06 Million7.75% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$2.78 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$1.97 Million0.42% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $33.8M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...